Mesenchymal Stem Cell Therapy on Tendon/Ligament Healing.

Area of Science:

• Regenerative Medicine
• Immunology
• Biomaterials Science

Background:

• Ligament and tendon rupture healing typically results in scar tissue, compromising function.
• Early suppression of inflammation is key to achieving more regenerative healing.
• Mesenchymal stem/stromal cells (MSCs) can modulate the immune response during healing by reprogramming macrophages.

Purpose of the Study:

• To investigate the efficacy of MSCs in treating ligament and tendon injuries by modulating the inflammatory response.
• To evaluate the dose-dependent effects of MSCs on ligament healing.
• To assess the impact of pre-conditioned MSCs on inflammation and tissue repair.

Main Methods:

• Allogeneic mesenchymal stem/stromal cells (MSCs) were administered to rat medial collateral ligament (MCL) and Achilles tendon injury models.
• Dose-dependency studies compared low (1 × 10^6) and high (4 × 10^6) doses of MSCs.
• Pre-conditioned MSCs, designed for enhanced anti-inflammatory properties, were compared to unconditioned MSCs.

Main Results:

• A low dose of MSCs reduced inflammation and M1 macrophages in MCL healing, improving ligament strength.
• Pre-conditioned MSCs significantly decreased inflammation by shifting macrophages from M1 to M2 phenotypes.
• Treatment with pre-conditioned MSCs restored tissue strength to levels comparable to intact tissue.

Conclusions:

• MSC therapy holds promise for improving ligament and tendon healing.
• Pre-conditioning MSCs enhances their anti-inflammatory and regenerative capabilities.
• MSC treatment, particularly with pre-conditioned cells, promotes a more robust, paracrine-mediated immunosuppressive response for superior tissue repair.